Pioneering GTPase and Oncogene Product Development Since 2010
shoppingCardistributornews

Email Us:info@neweastbio.com

Call Us:(+1) 610-945-2007

Human CB1 full length protein

12227

Size:100 μg Price:$ 1600 Brand:NewEast Place of Origin:USA Immunogen:

Add to cart Buy now Download Datasheet MSDS
Product Description Reference citations(0) Related Products
Cat.#:     12227
Product Name:   Human CB1 Full Length Protein
Size :    10 µg, 50 µg and 100 µg
Synonyms:   CANN6; CB-R; CNR1; CB1A; CB1K5; CB1R; CNR
Target:    CB1
UNIPROT ID:    P21554
Description:    Human CB1 full length protein membrane nanoparticles (MNPs)
Background:     The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene.
Species/Host:    HEK293
Molecular Weight:    The human full length CB1 Protein has a MW of 52.7 kDa
Formulation & Reconstitution:    Lyophilized from nanodisc solubilization buffer (20 mM Tris-HCl, 150 mM NaCl, pH 8.0). Normally 5% – 8% trehalose is added as protectants before lyophilization.
Storage & Shipping:    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Figure1. Elisa plates were pre-coated with 0.5 µg/per well purified human CB1 full length membrane nanoparticles. Serial diluted anti-CB1 monoclonal antibody (28488) solutions were added, washed, and incubated with secondary antibody before Elisa reading. From above data, the EC50 for anti-CB1 monoclonal antibody binding with CB1 full length membrane nanoparticles is 439.6ng/ml.

Figure2. FACS analysis of CB1 MNPs A. Negative Control 1: CB1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CB1 antibody (28057) at 2µg/ml, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CB1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2µg/ml, followed by Goat anti-human IgG 488 secondary antibody. D. CB1 full length membrane nanoparticles samples were stained with anti-CB1 antibody (28057) at 2µg/ml, followed by Goat anti-human IgG 488 secondary antibody.
Reference citations
    No data available

Select By Alphabet

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z